Cable Hill Partners’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-20
Closed -$1K 218
2019
Q1
$1K Hold
20
﹤0.01% 791
2018
Q4
$1K Hold
20
﹤0.01% 755
2018
Q3
$2K Hold
20
﹤0.01% 705
2018
Q2
$3K Hold
20
﹤0.01% 764
2018
Q1
$2K Hold
20
﹤0.01% 812
2017
Q4
$2K Hold
20
﹤0.01% 851
2017
Q3
$2K Hold
20
﹤0.01% 914
2017
Q2
$2K Hold
20
﹤0.01% 664
2017
Q1
$2K Hold
20
﹤0.01% 657
2016
Q4
$2K Hold
20
﹤0.01% 643
2016
Q3
$2K Hold
20
﹤0.01% 686
2016
Q2
$3K Hold
20
﹤0.01% 580
2016
Q1
$3K Hold
20
﹤0.01% 541
2015
Q4
$3K Hold
20
﹤0.01% 532
2015
Q3
$2K Hold
20
﹤0.01% 625
2015
Q2
$3K Hold
20
﹤0.01% 635
2015
Q1
$2K Hold
20
﹤0.01% 658
2014
Q4
$2K Buy
+20
New +$2.63K ﹤0.01% 630

Other funds holding CLB

Cable Hill Partners's CLB Position: Q2 2019 in Review

Cable Hill Partners sold out of Core Laboratories (CLB) in Q2 2019, closing a stake of 20 shares — an estimated $1K sold.

Cable Hill Partners first reported a position in CLB in Q4 2014 and held it in 18 quarters. The position peaked at $3K in Q2 2018. 304 funds tracked by Wall St. Rank hold CLB as of Q2 2019.

  • Cable Hill Partners reported no remaining Core Laboratories position as of Q2 2019 after selling out during the quarter.
  • Cable Hill Partners sold 20 Core Laboratories shares in Q2 2019, an estimated $1K.
  • Cable Hill Partners first reported a position in Core Laboratories in Q4 2014 and held it in 18 quarters.
  • Cable Hill Partners's Core Laboratories position peaked at $3K in Q2 2018.
  • 304 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2019.

Based on Cable Hill Partners's 13F filing for Q2 2019, filed 6 Aug 2019.